IDH1 and glioma: From the analysis of the correlation between the molecular expression and the clinical subtypes, we could find that LUZP2 of IDH mutant cells decreased, which indicates that the neuroendocrine function of IDH mutant glioma cells is worse, which may be related to the role of IDH.